CareDx Inc expected to post a loss of 27 cents a share - Earnings Preview

CareDx

24/02/2024 24:04

* CareDx Inc  CDNA.OQ   CDNA.O  is expected to show a fall
in
quarterly revenue when it reports  results on February 28 for
the period ending December 31 2023
    * The Brisbane California California-based  company is
expected to
report a 22.7% decrease in revenue to $63.655 million from
$82.38 million a year ago, according to the mean estimate from 7
analysts, based on LSEG data. (Revenue is on total revenue
basis)
    * ​LSEG's mean analyst estimate for CareDx Inc is for a loss
of 27
cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CareDx Inc
is
$12.00​, above​ its last closing price of $8.27. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.40       -0.40      -0.18     Beat    54.5
 Jun. 30 2023  -0.34       -0.31      -0.18     Beat    41.9
 Mar. 31 2023  -0.10       -0.11      -0.11     Met     -1.9​
 Dec. 31 2022  -0.08       -0.09      -0.07     Beat    18.8
 ​​Sep.        -0.14       -0.14      -0.06     Beat    57.1
 30 2022                                                
 Jun. 30 2022  -0.11       -0.11      -0.13     Missed  -16.1​
 Mar. 31 2022  -0.05       -0.05      -0.13     Missed  -160
 Dec. 31 2021  0.02        0.03       -0.03     Missed  -192.3
 This summary was machine generated February 24 at 00:04 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)